Bar Harbor Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.17M Buy
173,222
+686
+0.4% +$17.9K 0.22% 90
2026
Q1
$4.84M Sell
172,536
-6,276
-4% -$167K 0.28% 82
2025
Q4
$4.45M Buy
178,812
+5,308
+3% +$134K 0.26% 87
2025
Q3
$4.42M Buy
173,504
+33
+0% +$815 0.27% 86
2025
Q2
$4.2M Sell
173,471
-1,269
-0.7% -$29.6K 0.27% 86
2025
Q1
$4.43M Sell
174,740
-3,062
-2% -$80.1K 0.29% 80
2024
Q4
$4.72M Buy
177,802
+369
+0.2% +$10K 0.31% 83
2024
Q3
$5.13M Sell
177,433
-869
-0.5% -$25.4K 0.33% 78
2024
Q2
$4.99M Sell
178,302
-1,772
-1% -$48.8K 0.33% 79
2024
Q1
$5M Sell
180,074
-38,096
-17% -$1.06M 0.33% 81
2023
Q4
$6.28M Sell
218,170
-21,781
-9% -$658K 0.47% 57
2023
Q3
$7.96M Sell
239,951
-20,185
-8% -$714K 0.63% 46
2023
Q2
$9.54M Buy
260,136
+8,956
+4% +$349K 0.73% 41
2023
Q1
$10.2M Buy
251,180
+125
+0% +$5.4K 0.82% 38
2022
Q4
$12.9M Buy
251,055
+356
+0.1% +$17.1K 1.03% 30
2022
Q3
$11M Sell
250,699
-5
-0% -$243 0.95% 30
2022
Q2
$13.1M Buy
250,704
+32,898
+15% +$1.68M 1.05% 22
2022
Q1
$11.3M Buy
217,806
+21,873
+11% +$1.13M 1.01% 30
2021
Q4
$11.6M Sell
195,933
-1,745
-0.9% -$86.5K 0.98% 30
2021
Q3
$8.5M Buy
197,678
+284
+0.1% +$12.6K 0.8% 39
2021
Q2
$7.73M Sell
197,394
-2,152
-1% -$83.7K 0.72% 42
2021
Q1
$7.23M Sell
199,546
-4,305
-2% -$153K 0.7% 42
2020
Q4
$7.5M Sell
203,851
-10,624
-5% -$390K 0.75% 42
2020
Q3
$7.47M Sell
214,475
-8,156
-4% -$286K 0.83% 40
2020
Q2
$6.91M Sell
222,631
-19,145
-8% -$650K 0.8% 43
2020
Q1
$7.49M Sell
241,776
-40,132
-14% -$1.37M 1.01% 29
2019
Q4
$10.5M Sell
281,908
-16,544
-6% -$589K 1.15% 24
2019
Q3
$10.2M Buy
298,452
+7,528
+3% +$274K 1.18% 25
2019
Q2
$12M Buy
290,924
+22,043
+8% +$875K 1.39% 19
2019
Q1
$10.8M Sell
268,881
-572
-0.2% -$22.9K 1.3% 22
2018
Q4
$11.2M Sell
269,453
-7,878
-3% -$327K 1.48% 18
2018
Q3
$11.6M Buy
277,331
+31
+0% +$1.19K 1.32% 23
2018
Q2
$9.54M Sell
277,300
-5,853
-2% -$200K 1.15% 26
2018
Q1
$9.53M Sell
283,153
-1,457
-0.5% -$50.1K 1.17% 25
2017
Q4
$9.78M Sell
284,610
-3,260
-1% -$111K 1.14% 23
2017
Q3
$9.75M Sell
287,870
-10,409
-3% -$335K 1.18% 22
2017
Q2
$9.51M Sell
298,279
-31,448
-10% -$992K 1.14% 23
2017
Q1
$10.7M Sell
329,727
-54,698
-14% -$1.72M 1.25% 20
2016
Q4
$11.8M Sell
384,425
-3,101
-0.8% -$94.7K 1.31% 19
2016
Q3
$12.5M Sell
387,526
-10,800
-3% -$361K 1.41% 17
2016
Q2
$13.3M Buy
398,326
+16,348
+4% +$522K 1.55% 17
2016
Q1
$10.7M Buy
381,978
+985
+0.3% +$28.1K 1.31% 20
2015
Q4
$11.7M Sell
380,993
-1,243
-0.3% -$39.1K 1.47% 16
2015
Q3
$11.4M Sell
382,236
-5,142
-1% -$165K 1.51% 17
2015
Q2
$12.3M Sell
387,378
-2,918
-0.7% -$95.1K 1.5% 16
2015
Q1
$12.9M Sell
390,296
-1,106
-0.3% -$35.2K 1.56% 17
2014
Q4
$11.6M Sell
391,402
-313
-0.1% -$8.97K 1.44% 19
2014
Q3
$11M Sell
391,715
-2,143
-0.5% -$60.1K 1.41% 19
2014
Q2
$11.1M Sell
393,858
-1,931
-0.5% -$55K 1.39% 20
2014
Q1
$12.1M Buy
395,789
+4,086
+1% +$122K 1.55% 16
2013
Q4
$11.4M Sell
391,703
-894
-0.2% -$26K 1.48% 19
2013
Q3
$10.7M Sell
392,597
-1,599
-0.4% -$43.5K 1.5% 17
2013
Q2
$10.5M Buy
+394,196
New +$10.9M 1.52% 17

Other funds holding PFE

Bar Harbor Wealth Management's PFE Position: Q2 2026 in Review

Bar Harbor Wealth Management increased its Pfizer (PFE) stake by 0.4% in Q2 2026, buying an estimated $17.9K and bringing the position to 173,222 shares worth $4.17M. The position accounts for 0.22% of the portfolio, ranked #90.

Bar Harbor Wealth Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.3M in Q2 2016. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bar Harbor Wealth Management held 173,222 shares of Pfizer worth $4.17M as of Q2 2026.
  • Bar Harbor Wealth Management bought 686 Pfizer shares in Q2 2026, an estimated $17.9K.
  • Pfizer made up 0.22% of Bar Harbor Wealth Management's portfolio in Q2 2026, its #90 holding.
  • Bar Harbor Wealth Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Bar Harbor Wealth Management's Pfizer position peaked at $13.3M in Q2 2016.
  • 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bar Harbor Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.